Netrin-4 induces lymphangiogenesis in vivo.
Netrin-4, a laminin-related secreted protein is an axon guidance cue recently shown essential outside of the nervous system, regulating mammary and lung morphogenesis as well as blood vascular development. Here, we show that Netrin-4, at physiologic doses, induces proliferation, migration, adhesion, tube formation and survival of human lymphatic endothelial cells in vitro comparable to well-characterized lymphangiogenic factors fibroblast growth factor-2 (FGF-2), hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A), and vascular endothelial growth factor-C (VEGF-C). Netrin-4 stimulates phosphorylation of intracellular signaling components Akt, Erk and S6, and their specific inhibition antagonizes Netrin-4-induced proliferation. Although Netrin receptors Unc5B and neogenin, are expressed by human lymphatic endothelial cells, suppression of either or both does not suppress Netrin-4-promoted in vitro effects. In vivo, Netrin-4 induces growth of lymphatic and blood vessels in the skin of transgenic mice and in breast tumors. Its overexpression in human and mouse mammary carcinoma cancer cells leads to enhanced metastasis. Finally, Netrin-4 stimulates in vitro and in vivo lymphatic permeability by activating small GTPases and Src family kinases/FAK, and down-regulating tight junction proteins. Together, these data provide evidence that Netrin-4 is a lymphangiogenic factor contributing to tumor dissemination and represents a potential target to inhibit metastasis formation.
Larrieu-Lahargue
Frederic
F
Program in Molecular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
Welm
Alana L
AL
Thomas
Kirk R
KR
Li
Dean Y
DY
D000818:Animals; D001943:Breast Neoplasms / Q000098:blood supply / Q000235:genetics / Q000473:pathology; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D042783:Endothelial Cells / Q000166:cytology* / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D042583:Lymphangiogenesis; D042601:Lymphatic Vessels / Q000166:cytology* / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism*; D000075386:Netrin Receptors; D000075385:Netrins; D011956:Receptors, Cell Surface / Q000378:metabolism; D012867:Skin / Q000378:metabolism
D008565:Membrane Proteins; C498815:NTN4 protein, human; D009414:Nerve Growth Factors; D000075386:Netrin Receptors; D000075385:Netrins; C416214:Ntn4 protein, mouse; D011956:Receptors, Cell Surface; C532445:UNC5B protein, human; C091279:neogenin
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16210-5
15520390
EMBO J. 2005 Aug 17;24(16):2885-95
16052207
Biochim Biophys Acta. 2009 Apr;1795(2):137-51
19162129
Int J Cancer. 2009 Dec 15;125(12):2747-56
19569051
J Biol Chem. 2007 Aug 17;282(33):23750-8
17588941
Cancer Cell. 2008 Apr;13(4):331-42
18394556
Mol Cell Biol. 2008 Jun;28(12):4026-39
18411305
Science. 1997 May 30;276(5317):1423-5
9162011
J Exp Med. 2007 Oct 1;204(10):2349-62
17846148
Br J Cancer. 2009 Jul 21;101(2):327-34
19568240
J Cell Biol. 2004 Oct 25;167(2):223-9
15504909
Cardiovasc Res. 2001 Feb 16;49(3):507-21
11166264
J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
18565824
Cancer Cell. 2002 Apr;1(3):219-27
12086857
Gastroenterology. 2008 Oct;135(4):1248-57
18692059
J Cell Biol. 2000 Oct 16;151(2):221-34
11038171
Cancer Sci. 2007 May;98(5):726-33
17425689
J Clin Invest. 2004 Apr;113(7):1040-50
15057311
Exp Cell Res. 2009 Mar 10;315(5):784-94
19094984
Dev Cell. 2009 Apr;16(4):614-20
19386270
Cancer Biol Ther. 2007 May;6(5):743-8
17387275
Dev Cell. 2003 Mar;4(3):371-82
12636918
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7595-600
19383784
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8868-73
12070340
Nat Rev Mol Cell Biol. 2007 Apr;8(4):296-306
17356579
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14729-34
16203981
Eur J Cancer. 2007 Jul;43(11):1748-54
17570654
Science. 2006 Aug 4;313(5787):640-4
16809490
Pathol Oncol Res. 2008 Sep;14(3):299-306
18386163
Int J Cancer. 2002 Apr 20;98(6):946-51
11948478
Cancer Res. 1992 Mar 15;52(6):1399-405
1540948
Eur J Cancer. 2004 Dec;40(18):2717-25
15571953
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12491-6
18719102
FASEB J. 2002 Jul;16(9):922-34
12087053
Circ Res. 2004 Mar 19;94(5):664-70
14739162